In obese rats, administration of COX-2 by celecoxib, a COX-2 specific inhibitor, significantly reversed obesity-induced chronic inflammation and insulin resistance. The gene discussed is PTGS2; the disease is obesity due to melanocortin 4 receptor deficiency.